Antimicrobial Activity of Ankaferd Blood Stoppera (R) Against Nosocomial Bacterial Pathogens

View/Open
Date
2010
Author
Saribas, Zeynep
Sener, Burcin
Haznedaroglu, Ibrahim C.
Hascelik, Gulsen
Kirazli, Serafettin
Goker, Hakan
publications
32
supporting
3
mentioning
30
contrasting
0
Smart Citations
32
3
30
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

xmlui.mirage2.itemSummaryView.MetaData
Show full item record
Abstract
The aim of this study is to investigate the in vitro antimicrobial activity of Ankaferd Blood StopperA (R) against methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus species, Escherichia coli, Pseudomonas species, Acinetobacter species and Klebsiella species of nosocomial origin. Ankaferd inhibited growth in 72.4% to 100% of the bacteria tested, depending on the type of the isolate. As a result, it can be stated that Ankaferd inhibits the in vitro growth of nosocomial bacteria. This is a novel, important finding since severe hospital infections coexist with many hemostatic disorders, and the use of Ankaferd may increase hemostatic potential in such clinical conditions.
URI
https://doi.org/10.2478/s11536-009-0140-4
http://hdl.handle.net/11655/16422
xmlui.mirage2.itemSummaryView.Collections